Powder: -20°C for 3 years | In solvent: -80°C for 1 year
INCA-6 (Triptycene-1,4-quinone) is a cell-permeable NFAT inhibitor. INCA-6 inhibits of CN-NFAT signaling by targeting of NFAT(P) substrate to the calcineurin (CN) phosphatase site.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,500 | |||
10 mg | 在庫あり | ¥ 20,000 | |||
25 mg | 在庫あり | ¥ 39,500 | |||
50 mg | 在庫あり | ¥ 76,500 | |||
100 mg | 在庫あり | ¥ 130,000 | |||
500 mg | 在庫あり | ¥ 282,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 19,000 |
説明 | INCA-6 (Triptycene-1,4-quinone) is a cell-permeable NFAT inhibitor. INCA-6 inhibits of CN-NFAT signaling by targeting of NFAT(P) substrate to the calcineurin (CN) phosphatase site. |
別名 | Triptycene-1,4-quinone |
分子量 | 284.31 |
分子式 | C20H12O2 |
CAS No. | 3519-82-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.84 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
INCA-6 3519-82-2 Others factors inhibit NFAT microvascular Triptycene-1,4-quinone transcription endothelial Inhibitor retinopathy oxygen-induced retinal neovascularization INCA6 INCA 6 inhibitor